Shining 3D Non-Contact Laser Tracking System for 3D Scanner for Inspection and for 3D Measurement

Name: Shining 3D Non-Contact Laser Tracking System for 3D Scanner for Inspection and for 3D Measurement
Brand: Shining 3d Tech Co., Ltd.
SKU: 2297486865

Zhejiang, ChinaShining 3d Tech Co., Ltd.

US$45,000.00-65,000.00

1 Piece

Product profile

Customization

Available

After-sales Service

Online Support

Warranty

1 Year

Model NO.

FreeScan Trak Nova

Style

Portable

Interface Type

Wireless & Wired Mode (Fiber Optic)

Network Scanning

Support Network

Certification

ISO, CE, FCC, RoHS, Weee, Kc, FDA, Ukca, IP50, Tisax

Accuracy

0.02 mm

Resolution

0.01 -10 mm

Volumetric Accuracy

0.062 mm (12 M³)

Volumetric Accuracy with Vpg

0.046 + 0.012 mm/M

Scan Speed

6,140,000 Points/S

Scanning Modes

High-Speed Detailed Deep Pockets

Flexible Fov

up to 2600 × 2200 mm

Depth of Field

Te Nova: 380 mm (170 ~ 550 mm); Ue Nova: 2700 mm

Lead Time

10-15 Days

Accuracy Certification

Vdi/VDE 2634 Part 3 & ISO 10360 Certified

Transport Package

Carton Box

Specification

TE Nova: 1.2 kg; UE Nova: 1.6 kg

Trademark

SHINING 3D

Origin

Hangzhou, China

HS Code

9031499000

Key features

Dynamic Tracking Scan: Real-time tracking technology captures fine details in confined spaces with wireless agility.

High-Speed Scanning: Scans up to 6,140,000 points per second with multiple modes for speed and detail.

Video Photogrammetry: Patented VPG technology eliminates coded markers for real-time accuracy verification.

Certified Metrology Accuracy: Verified in ISO 17025 lab against VDI/VDE 2634 Part 3 and ISO 10360 standards.

Portable & Lightweight: Carbon fiber structure with TE Nova at 1.2 kg and UE Nova at 1.6 kg for easy mobility.

Swappable Batteries: Detachable batteries allow uninterrupted workflow during long projects or remote locations.

Comprehensive Certifications: Includes CE, FCC, ROHS, FDA, UKCA, IP50, and ISO 17025 accredited lab calibration.

Company profile

Years of Export ExperienceExhibition ExperienceNational Award receivedQuality Assurance

Shining 3d Tech Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 22 years CertifiedNearest Port: Shanghai portAverage Response Time: ≤2.02h

AI-Powered supplier vetting

SummaryThe supplier demonstrates broad customization capability, OEM/ODM availability, in-stock capacity, quality assurance, and participation in an identified offline trade show. It reports 22 years of export experience, one design award, one national science and technology progress award, and certifications or registrations including KGMP, MDSAP, CE, FDA, FCC, and CNAS-related laboratory capability. However, important management and service controls are weak or undocumented: there is no valid manufacturing-capacity contract with related subcontractors, no overseas warehouse, showroom, agent, or branch, and no written procedures or records for supplier approval, corrective and preventive actions, customer complaints, or service-capability assessment. R&D evidence is mixed: ODM and private mold capabilities are reported, but no new products were developed in the past year, no patents are reported, and key design documentation and an SDK are unavailable.

Supplier typeThe stated business scope permits production of Class II and Class III medical devices and related internet information services. The company description also reports KGMP and MDSAP certification and registrations or certifications such as CE, FDA, or FCC, indicating a medical-device-oriented manufacturer rather than a general trading-only supplier.

CertificationsThe supplier reports KGMP and MDSAP certification, international product-standard certifications or registrations including CE, FDA, or FCC, and CNAS certification connected with its testing and calibration laboratory system. These are explicit certification-related strengths, although the slices do not provide certificate numbers, scopes, or validity dates.

After-Sales capabilityThe supplier has in-stock service capacity and can participate in offline trade shows, but it has no overseas warehouse, showroom, agent, or branch, and reports zero countries with overseas services. Customer complaint handling and corrective/preventive action lack written procedures or records, while service-capability assessment also lacks documented procedures, indicating limited formalized after-sales infrastructure.

R&D capabilityThe supplier offers ODM services, has private mold designs, uses CAD, and reports one internationally recognized design award and one national science and technology progress award. However, it reports no new products in the past year, zero R&D patents, no available SDK, and no design input, output, review, verification, or validation documents available for audit, so innovation capability is supported in some areas but not comprehensively documented.

Production capacityThe supplier reports production authorization for Class II and Class III medical devices, quality assurance in quality-control processes, in-stock capacity, and one-month average lead times in both peak and off-season periods. Nevertheless, it has no valid manufacturing-capacity contract with related subcontractors, and finished products are checked by packing staff, while no written service-capability assessment procedures or records are maintained.

Customization capabilityThe supplier explicitly supports customization from samples, designs, full customization, flexible customization, and minor customization. Its ODM service, CAD capability, and private mold designs further support product-development customization.

Client casesThe supplier reports OEM service for well-known brands and participation in TCT Asia 2026, providing some evidence of market-facing experience. However, no named customers, project descriptions, or independently verifiable case details are provided, so the customer-case evidence is limited.